← brief for 2026-08-18 · Slowing decline

Evolocumab for severe refractory hypercholesterolemia in a child with steroid-resistant nephrotic syndrome and membranous nephropathy

Paper D Peer reviewed Preclinical

Key takeaways

This case report describes a child with kidney disease and triple-positive antiphospholipid syndrome who received eculizumab. The drug was used to treat complement-mediated glomerulonephritis.

Who did this work

Masato Itano (Fujita Health University Hospital) · Takuma Ando (Fujita Health University Hospital) · Tomomi Kondoh (Fujita Health University Hospital) · Yuji Matsumoto (Fujita Health University Hospital) · Naonori Kumagai (Fujita Health University Hospital) · Yohei Ikezumi (Fujita Health University Hospital)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-17
https://doi.org/10.1007/s00467-026-07521-1